Texas Permanent School Fund cut its stake in Clorox Company (The) (NYSE:CLX) by 3.4% during the second quarter, according to its most recent filing with the SEC. The fund owned 36,189 shares of the company’s stock after selling 1,289 shares during the period. Texas Permanent School Fund’s holdings in Clorox Company (The) were worth $4,822,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of CLX. Korea Investment CORP boosted its position in shares of Clorox Company (The) by 938.9% in the first quarter. Korea Investment CORP now owns 178,197 shares of the company’s stock valued at $24,026,000 after buying an additional 161,044 shares during the period. Crossvault Capital Management LLC boosted its position in shares of Clorox Company (The) by 3.8% in the first quarter. Crossvault Capital Management LLC now owns 34,684 shares of the company’s stock valued at $4,676,000 after buying an additional 1,285 shares during the period. Ameriprise Financial Inc. boosted its position in shares of Clorox Company (The) by 2.4% in the first quarter. Ameriprise Financial Inc. now owns 1,076,072 shares of the company’s stock valued at $146,932,000 after buying an additional 25,110 shares during the period. Destination Wealth Management boosted its position in shares of Clorox Company (The) by 14.0% in the first quarter. Destination Wealth Management now owns 30,225 shares of the company’s stock valued at $4,075,000 after buying an additional 3,716 shares during the period. Finally, Geode Capital Management LLC boosted its position in shares of Clorox Company (The) by 4.3% in the first quarter. Geode Capital Management LLC now owns 1,247,940 shares of the company’s stock valued at $168,019,000 after buying an additional 51,563 shares during the period. Hedge funds and other institutional investors own 70.29% of the company’s stock.

Shares of Clorox Company (CLX) opened at 134.31 on Friday. Clorox Company has a 52-week low of $111.24 and a 52-week high of $141.76. The company has a market cap of $17.34 billion, a PE ratio of 25.18 and a beta of 0.40. The stock’s 50 day moving average is $133.58 and its 200 day moving average is $133.56.

Clorox Company (The) (NYSE:CLX) last posted its quarterly earnings data on Thursday, August 3rd. The company reported $1.53 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.49 by $0.04. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. The firm had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.65 billion. During the same period in the prior year, the company earned $1.30 EPS. The firm’s revenue was up 2.9% compared to the same quarter last year. Equities analysts forecast that Clorox Company will post $5.67 EPS for the current year.

TRADEMARK VIOLATION NOTICE: This story was published by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are viewing this story on another domain, it was illegally copied and reposted in violation of United States and international copyright and trademark laws. The original version of this story can be accessed at https://theolympiareport.com/2017/08/12/texas-permanent-school-fund-sells-1289-shares-of-clorox-company-the-clx.html.

CLX has been the topic of several recent research reports. Deutsche Bank AG reiterated a “hold” rating and issued a $137.00 price objective (up previously from $126.00) on shares of Clorox Company (The) in a research note on Saturday, July 22nd. Vetr upgraded shares of Clorox Company (The) from a “hold” rating to a “buy” rating and set a $139.67 target price on the stock in a research note on Monday, April 24th. Jefferies Group LLC started coverage on shares of Clorox Company (The) in a research note on Tuesday, April 18th. They set a “hold” rating and a $138.00 target price on the stock. BMO Capital Markets restated a “buy” rating and set a $136.00 target price on shares of Clorox Company (The) in a research note on Thursday, May 4th. Finally, Zacks Investment Research cut shares of Clorox Company (The) from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. Two investment analysts have rated the stock with a sell rating, ten have issued a hold rating and three have issued a buy rating to the company. Clorox Company (The) has a consensus rating of “Hold” and an average target price of $129.05.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Company (The) (NYSE:CLX).

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with Analyst Ratings Network's FREE daily email newsletter.